IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,708 | -96.0% | 1,478 | -95.4% | 0.00% | -100.0% |
| Q2 2023 | $1,911,285 | -48.9% | 31,876 | -57.9% | 0.00% | 0.0% |
| Q1 2023 | $3,740,384 | +177.1% | 75,655 | +219.9% | 0.00% | – |
| Q4 2022 | $1,349,648 | +184.1% | 23,649 | +133.6% | 0.00% | – |
| Q3 2022 | $475,000 | +79.2% | 10,122 | +42.6% | 0.00% | – |
| Q2 2022 | $265,000 | +5.6% | 7,096 | -15.6% | 0.00% | – |
| Q1 2022 | $251,000 | -22.3% | 8,408 | -11.0% | 0.00% | – |
| Q4 2021 | $323,000 | -37.8% | 9,445 | -32.5% | 0.00% | – |
| Q3 2021 | $519,000 | +10.7% | 14,001 | +16.5% | 0.00% | – |
| Q2 2021 | $469,000 | -5.6% | 12,014 | +2.9% | 0.00% | – |
| Q1 2021 | $497,000 | – | 11,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
| RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
| Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
| Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
| GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
| Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
| Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
| COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |